YENNY GARCIA: Open Payments
NPI 1437613015 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 26 payments from 11 companies in 2025. Trend: 2023 $1,271 · 2024 $907 · 2025 $998
Food & beverage: $974Education: $24
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $267 |
| Adaptive Biotechnologies Corporation | 3 | $203 |
| Janssen Scientific Affairs, LLC | 2 | $169 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| Blueprint Medicines Corporation | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Legend Biotech USA Inc. | 1 | $37 |
| ABBVIE INC. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 2 | $24 |
Products named: DARZALEX, clonoSEQ, CARVYKTI, ABECMA, AYVAKIT, SCEMBLIX, AVYCAZ, ICLUSIG.
Industry payments across FL — which companies pay providers there.
